We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Philips Healthcare

Operates in Diagnostic Imaging Systems, Patient Care and Clinical Informatics, Customer Services, and Home Healthcare... read more Featured Products: More products

Download Mobile App




Data Management System Integrates Complex Image Data

By LabMedica International staff writers
Posted on 03 Jul 2017
A web-based data management system that enables researchers to integrate data from multiple sources including digital pathology and tissue imaging and share information over the Internet is now available.

Royal Philips (Amsterdam, the Netherlands) has launched its Xplore v4.0 comprehensive web-based image and big data management system. More...
Xplore provides a central hub to create, interrogate, share, and manage archives both for individual and collaborative studies. The user can define study hierarchy, datasets, and fields, and import whole slide or TMA (Tissue Micro Array) images.

TMA is an Xplore-related module designed to speed up research studies, which require manual scores of TMA cores. This powerful tool allows manual scoring of TMAs online, which facilitates the evaluation of new tissue biomarkers in TMAs quickly and easily. Using TMA scoring templates, map templates, and an automated de-arrayer, this module ensures that TMA cores will be rapidly segmented, identified, and sent out for scoring. With a single screen/interface for viewing and scoring, management of TMAs is greatly simplified for the pathologist.

Version 4.0 of Xplore comprises a major upgrade for both pharmaceutical and academic researchers, as it provides enhanced search capabilities, barcode support, data visualization tools, and third party image analysis vendor integration.

“Delivering on the promise of personalized medicine means that multiple data sources need to be integrated and analyzed,” said Russ Granzow, general manager of digital pathology solutions at Royal Philips. “Computational pathology research tools will be essential to move forward in our increasingly complex medical and research environment.”

Xplore v4.0 will be available in July 2017. Customers have the option to purchase the basic package or enhance it with custom additions such as the dedicated TMA module.


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
HPV Test
Allplex HPV28 Detection
Clinical Informatics Platform
CLARION™
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.